Rocuronium Bromide Injection shortage
Current 26 presentations · 11 manufacturers · first FDA posting Feb 15, 2023 · last update Oct 15, 2026
Manufacturers: Baxter Healthcare, Eugia US LLC, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company, Meitheal Pharmaceuticals, Inc., Mylan Institutional, a Viatris Company, Piramal Critical Care Inc., Sagent Pharmaceuticals, Sandoz Inc., XGen Pharmaceuticals DJB, Inc.
Stated reasons (per FDA): Delay in shipping of the drug; Demand increase for the drug
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) | Baxter Healthcare | Current Available |
— | Posted Feb 15, 2023 Updated Oct 2, 2026 | |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) | Baxter Healthcare | Current Available |
— | Posted Feb 15, 2023 Updated Oct 2, 2026 | |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted Feb 15, 2023 Updated Oct 2, 2026 |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) | Eugia US LLC | Current Available |
— | Check wholesalers for inventory | Posted Feb 15, 2023 Updated Oct 2, 2026 |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Next release November 2026. Check wholesalers for inventory. | Posted Feb 15, 2023 Updated Oct 6, 2026 |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Feb 15, 2023 Updated Oct 15, 2026 |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Estimated recovery: TBD | Posted Feb 15, 2023 Updated Oct 15, 2026 |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Next release October 2026. Check wholesalers for inventory. | Posted Feb 15, 2023 Updated Oct 6, 2026 |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Next release November 2026. Check wholesalers for inventory. | Posted Feb 15, 2023 Updated Oct 15, 2026 |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots will be available. Product will be made available as it is released. | Posted Feb 15, 2023 Updated Oct 14, 2026 |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots will be available. Product will be made available as it is released. | Posted Feb 15, 2023 Updated Oct 14, 2026 |
| Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Feb 15, 2023 Updated Oct 8, 2026 | |
| Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Feb 15, 2023 Updated Oct 8, 2026 | |
| Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Feb 15, 2023 Updated Oct 8, 2026 | |
| Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Feb 15, 2023 Updated Oct 8, 2026 | |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) | Meitheal Pharmaceuticals, Inc. | Current Available |
— | Posted Feb 15, 2023 Updated Aug 27, 2026 | |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11) | Meitheal Pharmaceuticals, Inc. | Current Available |
— | Posted Feb 15, 2023 Updated Aug 27, 2026 | |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted Feb 15, 2023 Updated Oct 5, 2026 | |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) | Mylan Institutional, a Viatris Company | Current Available |
— | Posted Feb 15, 2023 Updated Oct 5, 2026 | |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) | Piramal Critical Care Inc. | Current Available |
— | Posted Feb 15, 2023 Updated Sep 15, 2026 | |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) | Piramal Critical Care Inc. | Current Limited Availability |
Demand increase for the drug | On allocation | Posted Feb 15, 2023 Updated Sep 15, 2026 |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) | Sagent Pharmaceuticals | Current Available |
— | Posted Feb 15, 2023 Updated Oct 8, 2026 | |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) | Sandoz Inc. | Current Available |
— | Posted Feb 15, 2023 Updated Oct 8, 2026 | |
| Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) | Sandoz Inc. | Current Available |
— | Posted Feb 15, 2023 Updated Oct 8, 2026 | |
| Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) | XGen Pharmaceuticals DJB, Inc. | Current Available |
— | Tamarang is the application holder and X-Gen is the distributor/labeler | Posted Feb 15, 2023 Updated Sep 22, 2026 |
| Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) | XGen Pharmaceuticals DJB, Inc. | Current Available |
— | Tamarang is the application holder and X-Gen is the distributor/labeler | Posted Feb 15, 2023 Updated Sep 22, 2026 |